Clinical Trial Update: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether statins can reduce cardiac toxicity in patients with early-stage breast cancer receiving HER2-targeted therapy an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Statins

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Cardiac Toxicity, Early-stage Breast Cancer | Phase 2 | Status: RECRUITING